[{"id":"211eeb3f-139e-420f-ae87-06572b73ee2a","acronym":"PRECIOUS-01","url":"https://clinicaltrials.gov/study/NCT04751786","created_at":"2021-02-12T13:55:47.252Z","updated_at":"2024-07-02T16:35:10.395Z","phase":"Phase 1","brief_title":"Dose Escalation Study of Immunomodulatory Nanoparticles","source_id_and_acronym":"NCT04751786 - PRECIOUS-01","lead_sponsor":"Radboud University Medical Center","biomarkers":" CD20 • CD8 • CTAG1B • FOXP3","pipe":" | ","alterations":" CD20 positive","tags":["CD20 • CD8 • CTAG1B • FOXP3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PORT-3"],"overall_status":"Recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 01/11/2021","start_date":" 01/11/2021","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 07/01/2025","study_completion_date":" 07/01/2025","last_update_posted":"2024-04-10"}]